DKNG Return on Equity (ROE) Analysis
Updated 107h ago·SEC filings & market data
Key Takeaway
Return on equity (ROE) measures how much profit a company generates for each dollar of shareholder equity; at -21.1%, DKNG is currently destroying shareholder value, meaning losses exceed the equity base.
Sector Performance
9th percentileDKNG
-21.1%
Sector Median
13.2%
Sector Avg
16.4%
Prior Period
7.9%(Aug 2026)
Deep Analysis
Return on equity (ROE) measures how much profit a company generates for each dollar of shareholder equity; at -21.1%, DKNG is currently destroying shareholder value, meaning losses exceed the equity base.
This sits far below the sector median of 13.2%, placing the stock at the 9th percentile among peers, implying almost all competitors generate better returns on equity. The metric's trajectory is sharply downward: while year-over-year data is unavailable, the quarter-over-quarter change of -367.1% reflects a steep deterioration from the prior reading of 7.9%, the only historical value shown. The combination of an already-negative level and a collapsing trend signals elevated financial risk, as the company is not only
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about DKNG?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Learn More About Return on Equity (ROE)
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master DKNG's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full DKNG research report →DKNG
-21.1%
Sector Median
13.2%
Sector Avg
16.4%
How DKNG's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.